About this medicine
- Approved name
- Bayovac IBR Marker Vivum
- International non-proprietary name (INN) or common name
- bovine Herpes Virus type 1 (BHV-1), strain Difivac (IBR-Marker Virus, gE-negative), modified live (attenuated) virus
- Associated names
- Rhinobovin
- Marker lebend
- Rhinobovin Marker live
- RhinobovinMarker Viva
- Rhinobovin Marker Attenuato
- Rhinobovin Marker Viva Marcada
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/V/A/023b/001
- Type
- Article 78
Pharmacovigilance urgent measures: initiated when, as a result of the evaluation of veterinary pharmacovigilance data, a Member State considers that a marketing authorisation should be suspended, withdrawn or varied to restrict the indications or availability, amend the posology, add a contraindication or add a new precautionary measure.
Key dates and outcomes
- Opinion date
- 21/01/2000
- EC decision date
- 10/07/2000